NR4A1是声带纤维化的内源性抑制剂
本研究在大鼠声带损伤模型中观察NR4A1 mRNA表达的时间模式,并在人声带成纤维细胞(VFF)中通过小干扰RNA改变NR4A1表达,探究其对TGF-β1介导的纤维化基因转录、肌成纤维细胞分化和胶原凝胶收缩的调控作用。结果显示Nr4a1 mRNA在损伤后1天升高、7天达峰;敲低NR4A1导致COL1A1和TGF-β1上调(均P < .001),并增加α-SMA阳性细胞(P = .013)和收缩(P = .002)。结论认为NR4A1在声带健康或疾病中尚未被描述,这些数据为开发治疗策略提供了基础。
要点
- 大鼠声带损伤后Nr4a1 mRNA在1天升高、7天达峰。
- 人VFF中敲低NR4A1使COL1A1和TGF-β1上调(均P < .001)。
- 敲低NR4A1增加α-SMA阳性细胞(P = .013)和收缩(P = .002)。
核心结论
- NR4A1在声带健康或疾病中尚未被描述;声带损伤后TGF-β上调与NR4A1表达增加同时发生;这些数据为针对声带纤维化中持续TGF-β信号的治疗策略开发提供了基础。
研究设计与样本
- 在体和体外研究:在体定量大鼠声带损伤后NR4A1 mRNA表达的时间模式;体外用人VFF细胞系,采用小干扰RNA改变NR4A1表达,定量TGF-β1介导的纤维化相关基因转录、肌成纤维细胞分化和胶原凝胶收缩。
主要发现
- 大鼠声带损伤后Nr4a1 mRNA在1天增加、7天达峰。
- 人VFF中敲低NR4A1后,在TGF-β1刺激下COL1A1和TGF-β1上调(均P < .001)。
- 人VFF中敲低NR4A1后,在TGF-β1刺激下α-平滑肌肌动蛋白阳性细胞增加(P = .013)、收缩增加(P = .002)。
关键数值与推荐
- 敲低NR4A1后COL1A1和TGF-β1上调,均P < .001(人VFF,TGF-β1刺激)。
- 敲低NR4A1后α-SMA阳性细胞增加,P = .013(人VFF,TGF-β1刺激)。
- 敲低NR4A1后胶原凝胶收缩增加,P = .002(人VFF,TGF-β1刺激)。
- Nr4a1 mRNA在损伤后1天增加、7天达峰(大鼠声带损伤模型)。
临床怎么用
- 原文未报告临床实践推荐。
局限性
- 原文未述局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES/HYPOTHESIS: NR4A1 was recently identified as an endogenous inhibitor of transforming growth factor (TGF)-β-induced fibrosis, and the role of this nuclear receptor has not been elucidated in tissue health or the response to injury in the vocal folds. Given the clinical implications of vocal fold fibrosis, we investigated NR4A1 expression during vocal fold wound healing in vivo and the regulatory roles of NR4A1 on vocal fold fibroblasts (VFFs) in vitro with the ultimate goal of developing targeted therapies for this challenging patient population. STUDY DESIGN: In vivo and in vitro. METHODS: In vivo, the temporal pattern of NR4A1 mRNA expression was quantified following rat vocal fold injury. In vitro, the role of NR4A1 on TGF-β1-mediated transcription of genes underlying fibrosis as well as myofibroblast differentiation and collagen gel contraction was quantified in our human VFF line. Small interfering RNA was employed to alter NR4A1 expression to further elucidate this complex system. RESULTS: Nr4a1 mRNA increased 1 day after injury and peaked at 7 days. Knockdown of NR4A1 resulted in upregulation of COL1A1 and TGF-β1, with TGF-β1 stimulation (both P < .001) in VFFs. NR4A1 knockdown also resulted in increased α-smooth muscle actin-positive cells (P = .013) and contraction (P = .002) in response to TGF-β1. CONCLUSIONS: NR4A1 has not been described in vocal fold health or disease. Upregulation of TGF-β following vocal fold injury was concurrent with increased NR4A1 expression. These data provide a foundation for the development of therapeutic strategies given persistent TGF-β signaling in vocal fold fibrosis. LEVEL OF EVIDENCE: N/A Laryngoscope, 127:E317-E323, 2017.
引用
- Hiwatashi N, Bing R, Kraja I, et al. NR4A1 is an endogenous inhibitor of vocal fold fibrosis. Laryngoscope. 2017. PMID: 28581197. doi:10.1002/lary.26678
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。